Letter to the Editor: Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study

J Neurol Sci. 2024 Nov 15:466:123240. doi: 10.1016/j.jns.2024.123240. Epub 2024 Sep 11.

Authors

Mahnoor Aamir¹, Khadija Anwar², Shafin Bin Amin³, Rabbia Aqeel⁴

Affiliations

¹ Islamabad Medical and Dental College, Wadi-ul-ilm, Barakahu, Islamabad 45400, Pakistan.
² Dow International Medical College, Scheme 33, Gulzar-e-Hijri, Karachi 74200, Pakistan. Electronic address: [email protected].
³ Jinnah Postgraduate Medical Centre, Rafiqui H J Shaheed Road, Karachi 75510, Pakistan.
⁴ Shaheed Mohtarma Benazir Bhutto medical college, Lyari, Lyari Hospital Rd, Rangiwara Karachi, Karachi 75010, Pakistan.

PMID: 39289099
DOI: 10.1016/j.jns.2024.123240

No abstract available

Keywords: Headache; Letter to editor; Migraine; Tricaprilin.

Publication types

Letter